Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug crawled date : 2021 - 12 - 09 save search
BioCorRx Appoints Drug Delivery Expert Jie Shen, Ph.D., to Scientific Advisory Board
Published: 2021-12-09 (Crawled : 20:00) - biospace.com/
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
|
| O: 0.22%
H: 0.0%
C: 0.0%
drug liver drug delivery
Reuters Investigation Points to J&J Coverup for Diabetes Drug Risk
Published: 2021-12-09 (Crawled : 18:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
risk drug diabetes
New Studies Shed Light on Opioid-Related Drug Interactions
Published: 2021-12-09 (Crawled : 15:30) - prnewswire.com
TRHC | $10.5 -0.1% 1.3M
|
Technology Services
|
| O: -3.39%
H: 4.55%
C: -1.33%
drug opioid
Aligos Therapeutics Begins Dosing with NASH Drug Candidate, ALG-055009, in Healthy Volunteers in a Phase 1 First-in-Human Study
Published: 2021-12-09 (Crawled : 14:30) - biospace.com/
ALGS | $0.735 -7.33% -7.9% 140K
|
Health Technology
|
| O: -1.88%
H: 4.8%
C: -7.43%
alg-0550 health drug therapeutics phase 1 nash
CytoDyn Files for Expanded Access Use of Leronlimab for Multi-Drug Resistance HIV Patients
Published: 2021-12-09 (Crawled : 14:00) - biospace.com/
CYDY | $0.1509 0.06% 810K
|
Manufacturing
|
| O: 3.81%
H: 3.67%
C: -5.5%
drug hiv
VBI Vaccines Announces Filing of New Drug Submission for 3-Antigen Hepatitis B Vaccine to Health Canada
Published: 2021-12-09 (Crawled : 13:00) - vbivaccines.com
VBIV | $0.6396 1.57% 1.55% 160K
|
Health Technology
|
| O: 4.11%
H: 2.63%
C: -3.38%
new drug health hepatitis drug vaccine submission
Ocugen, Inc. Announces U.S. FDA Acceptance of Investigational New Drug Application to Initiate a Phase 1/2 Clinical Trial for Gene Therapy Candidate OCU400 to Treat Inherited Retinal Degeneration
Published: 2021-12-09 (Crawled : 12:30) - globenewswire.com
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
|
| O: 7.46%
H: 0.31%
C: -12.81%
ocu400 new drug fda application gene therapy drug trial fda acceptance phase 1 therapy retina
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.